Stockreport

Kineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla

Kineta, Inc.  (KA) 
PDF SEATTLE, June 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in on [Read more]